Harvard Bioscience forms scientific advisory board, names four industry leaders alongside CEO Duke
HBIO•Harvard Bioscience formed a five-member Scientific Advisory Board to guide research and development priorities and product roadmaps. CEO John Duke and four external leaders were named to the board, which is scheduled to meet quarterly.
1. Board appointments
The board includes President and CEO John Duke, Ryan Conder of STEMCELL Technologies, Aaron Goldman of Harvard Medical School, Ananda Devices CEO Keith Olson and venture capitalist Eric Richman. Duke previously led Plastic Molding Technology after 25 years at Corning; Richman is a director at LabConnect and SafeHeal and has held CEO roles.
